Cargando…
Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective
It is estimated that approximately one-third of patients with triple-negative breast cancer (TNBC) will develop brain metastases. The prognosis for patients with breast cancer brain metastasis has improved in the recent past, especially for hormone receptor and human epidermal growth factor receptor...
Autores principales: | Kadamkulam Syriac, Arun, Nandu, Nitish Singh, Leone, Jose Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760391/ https://www.ncbi.nlm.nih.gov/pubmed/35046721 http://dx.doi.org/10.2147/BCTT.S274514 |
Ejemplares similares
-
Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases
por: Laimito, Katerin Rojas, et al.
Publicado: (2016) -
Advances in the Management of Central Nervous System Metastases from Breast Cancer
por: Avila, Jorge, et al.
Publicado: (2022) -
Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer
por: Rojas L, Katerin, et al.
Publicado: (2019) -
Triple-negative breast cancer therapy: Current and future perspectives (Review)
por: Won, Kwang-Ai, et al.
Publicado: (2020) -
Immunotherapy for cancer in the central nervous system: Current and future directions
por: Binder, David C., et al.
Publicado: (2015)